Related Experiment Videos
[Leipzig neonatal screening center--experiences with introduction of screening for congenital hypothyroidism]
S Herden1, H Willgerodt, W Rotzsch
1Institut für Klinische Chemie und Laboratoriumsdiagnostik des Bereiches Medizin, Universität Leipzig.
Insights
Neonatal screening for congenital hypothyroidism in Saxony, Germany, identified an incidence of 1:3,200 newborns. Early therapy initiation is crucial, though organizational disparities in screening fee payments persist.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Context:
- Neonatal screening programs are vital for early detection of endocrine disorders.
- The paper details the implementation of congenital hypothyroidism screening in Saxony, Germany, post-reunification.
Purpose:
- To describe the development, results, and organizational aspects of neonatal screening for congenital hypothyroidism in Leipzig.
- To discuss the incidence rate and timeliness of treatment initiation.
- To highlight organizational challenges and propose improvements.
Summary:
- TSH measurement in blood spots of 65,000 newborns revealed a congenital hypothyroidism incidence of 1:3,200.
- Therapy initiation within three weeks of life was consistently achieved.
- Organizational disparities in screening fee payments present challenges.
Impact:
- Ensures timely treatment for congenital hypothyroidism, preventing developmental issues.
- Identifies areas for improved standardization in neonatal screening programs across federal states.
- Informs the preparation for neonatal screening of congenital adrenal hyperplasia.
Abstract:
The development of neonatal screening for congenital hypothyroidism in the GDR and particularly in Saxony after German reunification is described in this paper. The results of the studies and the experiences in respect of realisation and organisation of the screening for hypothyroidism in the screening centre of Leipzig are discussed. Measurement of TSH in the blood spot of about 65,000 newborn yielded an incidence rate of congenital hypothyroidism of 1:3,200. The onset of therapy within the first three weeks of life has been ensured until now since no children with congenital hypothyroidism were involved in cases of occasionally delayed blood sampling and/or postal delay. However, there has been some organisational disparity due to individually different handling of health insurance fund payments of screening fees for hypothyroidism in Saxony and also in the other federal states. The disadvantages of this lack of uniform regulations are explained. Neonatal screening for evidence of congenital adrenal hyperplasia by determining 17-alpha-hydroxyprogesterone, is under preparation.